ABVC BioPharma, Inc. ABVC 深 沪
已收盘 02-06 16:00:00 美东时间
1.74
+0.140
+8.75%
华盛通- 最 高1.77
- 今 开1.66
- 成交量 7.71万股
- 最 低 1.66
- 昨 收 1.60
- 总市值 4228.39万
- 52周最高 5.48
- 市盈率 静 --
- 换手率 0.32%
- 52周最低 0.46
- 委 比 93.94%
- 总股本 2430.11万
- 历史最高 116.90
- 量 比 0.91
- 振 幅 6.88%
- 历史最低 0.40
- 每 手 1
- 风险率 0.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ABVC BioPharma Q3 EPS $(0.05) Down From $(0.03) YoY, Sales $795.950K Up From $389.276K YoY
ABVC BioPharma (NASDAQ:ABVC) reported quarterly losses of $(0.05) per share. This is a 66.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $795.950 thousand in
2025-11-03 22:16
ABVC BioPharma Q2 EPS $(0.13) Down From $(0.09) YoY
ABVC BioPharma (NASDAQ:ABVC) reported quarterly losses of $(0.13) per share. This is a 44.44 percent decrease over losses of $(0.09) per share from the same period last year.
2025-08-14 05:40
快讯 | ABVC生物制药公司申请混合货架，最高达1亿美元 - SEC文件
ABVC Biopharma Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing
2025-05-23 04:02
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 72.6% to $0.47 during Wedne...
2025-05-22 01:06
'ABVC BioPharma Secures Japanese Patent For Its Natural MDD Treatment Candidate ABV-1504'
ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced
2025-05-09 23:05
ABVC BioPharma Reports Strong Financial Growth
The latest announcement is out from ABVC BioPharma, Inc. ( ($ABVC) ). In 2024, ...
2025-04-16 04:59
快讯 | ABVC生物制药公司 - 3月5日，李德斯·周辞去ABVC生物制药的首席财务官职务
ABVC Biopharma Inc - on March 5, Leeds Chow Resigns as CFO of ABVC Biopharma
2025-03-08 05:20
ABVC BioPharma gets $200K in cash from OncoX BioPharma
ABVC BioPharma (NASDAQ:ABVC) said it has received a $200K cash payment from OncoX BioPharma as part of its strategic licensing agreement for certain oncology-related products. The payment is the first...
2024-12-11 20:16
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb
ABVC BioPharma (NASDAQ:ABVC) has secured an additional $50,000 in licensing fees from AiBtl BioPharma, it said on Tuesday, sending shares up in premarket trade. ABVC (ABVC) shares rose +4.89% premark...
2024-10-22 21:09
ABVC BioPharma Receives $50,000 In Incremental Licensing Fees
With this payment, ABVC has received a total of $346,000 in licensing fees from its strategic partners, supporting our partner's belief in our mission. ABVC has received 23M AiBtl shares as part of the first milestone of
2024-10-22 20:51
